Analysts/Institutional Investor Meet/Con. Call Updates
- Strong revenue momentum with Q1 FY27 sales growing 38% YoY to ₹1,563 Cr on record volumes of 1,006 MW
- Substantial order book of 7.9 GW offering multi-year revenue visibility
- Strategic shift toward 70% backward integration into cells/wafers to mitigate supply chain risks
- Pivot toward higher-margin distribution sales target of 80 MW/month
- Severe operational margin collapse in Q1 FY27 where EBITDA margins dropped from 21% to 8%, causing PAT to crash 85% YoY
- Massive ₹5,600 Cr capex funded 70% via debt will heavily leverage the balance sheet and increase interest burden
- Existence of multiple Corporate Insolvency Resolution Process (CIRP) legal filings in late June 2026
- High vulnerability to raw material (wafer/cell) pricing shocks and ALMM policy shifts
- Multiple CIRP (Corporate Insolvency Resolution Process) legal filings logged in June 2026
- Missing disclosures on promoter holding, debt levels, and ROCE in point-in-time metrics
- Highly aggressive capex commitment (₹5,600 Cr) exceeding current market cap (₹5,481 Cr) amid crashing net profitability
Executive Summary
Vikram Solar's analyst call announcement on August 13, 2026, highlights Q1 FY27 revenue growth of 38% YoY and detailed plans for a massive ₹5,600 Cr capex program (downsized from 12 GW to 9 GW wafer/ingot capacity). While volume growth remains strong (1,006 MW shipped in Q1), profitability has suffered a catastrophic hit: Q1 FY27 PAT dropped ~85% YoY due to sharp margin compression (EBITDA margin falling to 8% from 21%). Combined with legal overhangs from CIRP filings in June 2026 and an aggressive 70:30 debt-funded capex plan, the company faces substantial execution, financial leverage, and governance risks.
Ramp-Aware Impact & Earnings Math
- Capex & Revenue Timeline: The ₹5,600 Cr project is scheduled to begin yielding cell production by Q4 FY27, with full 9 GW wafer-ingot integration taking 3+ years (FY27-FY29).
- Year-1 Uplift: With cell production starting late in FY27, Year-1 (FY27) revenue uplift is estimated at 10-12%, lifting FY27 revenue to ~₹3,750 Cr.
- Steady-State Revenue: Upon full commissioning (~FY29), backward integration could add ₹1,600–2,000 Cr in net top-line contribution, bringing steady-state revenues to ~₹5,000–5,500 Cr (+50% over TTM).
- Margin Compression & EPS Impact: Margins have collapsed from 20%+ to ~8% in Q1 FY27 due to cell price pass-throughs and freight inflation. Assuming a modest margin recovery to 10-12% operating margin, operating profit on ₹5,000 Cr revenue would be ~₹550 Cr. However, debt-funding ₹3,920 Cr (70% of ₹5,600 Cr capex) at a 9-10% interest rate adds ~₹350-390 Cr in annual interest expenses plus heavy depreciation. This will heavily dilute steady-state net profits, resulting in a potential negative to flat net EPS uplift relative to FY26 TTM EPS of ₹10.75.
Industry Context & Quality Evaluation
Solar module manufacturing is highly capital-intensive and subject to intense international competition and technology obsolescence. While the domestic market benefits from policy tailwinds (ALMM, DCR orders), pricing power is weak and gross margins depend on solar cell/wafer pricing cycles. Vikram Solar fails the quality gate due to missing ROCE disclosures, sudden margin compression, and significant financial leverage risks.
Valuation & Catalyst Freshness
The market cap stands at ₹5,481 Cr with a trailing P/E of 15.2x. However, trailing earnings reflect high margins from FY26 that are no longer present in Q1 FY27. On annualized Q1 FY27 earnings, forward valuation is significantly more expensive. Furthermore, the ₹5,589 Cr expansion plan was already announced on August 6, 2026, making this catalyst already priced in.
Scenario Analysis & Verdict
- Bull Case (+35% upside to ₹221): Fast stabilization of module prices, smooth Q4 FY27 cell commissioning, and successful equity raises to lower debt burdens.
- Base Case (+5% upside to ₹172): Moderately successful execution, high interest costs offsetting top-line growth, leaving earnings range-bound over 24-36 months.
- Bear Case (-40% downside to ₹98): Cost overruns on the ₹5,600 Cr capex, lingering CIRP legal issues, and sustained low EBITDA margins (6-8%) causing debt-servicing stress.
Verdict: UNLIKELY. The massive debt burden required for the expansion, combined with an 85% collapse in Q1 profitability and CIRP legal red flags, severely limits multibagger potential.